STOCK-BASED COMPENSATION- (Tables)

6 Months Ended

Sep. 30, 2023

Equity [Abstract]

Schedule of Stock-based Compensation Activity, by Award Type

The Company's stock-based compensation activity for the six months ended September 30, 2023 and 2022, by award type, was (dollars in thousands):

	For the six months ended
	September 30,
	2023		2022
Stock options	$	304	$	563
Restricted stock units, time-vesting	22,175		40,583
Restricted stock units, performance based	2,707		2,837
Diablo restricted stock awards	—		249
Data Plus Math ("DPM") acquisition consideration holdback	—		2,031
Acuity performance plan	165		531
DataFleets acquisition consideration holdback	2,267		3,021
Employee stock purchase plan	784		1,015
Directors stock-based compensation	625		688
Total non-cash stock-based compensation included in the condensed consolidated statements of operations	29,027		51,518
Less expense related to liability-based equity awards	(2,439)		(5,586)
Total non-cash stock-based compensation included in the condensed consolidated statements of equity	$	26,588	$	45,932

Schedule of Effect of Stock-based Compensation Expense on Income, by Financial Statement Line Item

The effect of stock-based compensation expense on income, by financial statement line item, was (dollars in thousands):

	For the six months ended
	September 30,
	2023		2022
Cost of revenue	$	1,258	$	2,456
Research and development	10,370		24,016
Sales and marketing	8,522		12,000
General and administrative	8,877		13,046
Total non-cash stock-based compensation included in the condensed consolidated statements of operations	$	29,027	$	51,518

Schedule of Share-based Compensation Arrangement by Share Based Payment Award, Future Expense

The following table provides the expected future expense for all of the Company's outstanding equity awards at September 30, 2023, by award type. The amount for fiscal 2024 represents the remaining six months ending March 31, 2024. All other periods represent fiscal years ending March 31 (dollars in thousands).

	For the years ending March 31,
	2024		2025		2026		2027		Total
Stock options	$	182	$	90	$	—	$	—	$	272
Restricted stock units	37,344		74,082		25,488		887		137,801
Employee stock purchase plan	226		—		—		—		226
Expected future expense	$	37,752	$	74,172	$	25,488	$	887	$	138,299

Schedule of Option Activity

Stock option activity for the six months ended September 30, 2023 was:  

				Weighted-average
		Weighted-average		remaining	Aggregate
	Number of	exercise price		contractual term	Intrinsic value
	shares	per share		(in years)	(in thousands)
Outstanding at March 31, 2023	524,911	$	18.39
Exercised	(144,106)	$	20.33		$	609
Forfeited or canceled	(2,410)	$	5.21
Outstanding at September 30, 2023	378,395	$	17.74	1.5	$	4,201
Exercisable at September 30, 2023	374,593	$	17.91	1.5	$	4,095

Schedule of Stock Options Outstanding and Exercisable

A summary of stock options outstanding and exercisable as of September 30, 2023 was:

					Options outstanding				Options exercisable
Range of						Weighted-average	Weighted-average			Weighted-average
exercise price					Options	remaining	exercise price		Options	exercise price
per share					outstanding	contractual life	per share		exercisable	per share
$	—	—	$	9.99	31,142	5.1 years	$	1.01	27,340	$	1.02
$	10.00	—	$	19.99	182,603	1.6 years	$	17.49	182,603	$	17.49
$	20.00	—	$	24.99	164,650	0.8 years	$	21.18	164,650	$	21.18
					378,395	1.5 years	$	17.74	374,593	$	17.91

Schedule of Time-vesting Restricted Stock Unit Activity

RSU activity for the six months ended September 30, 2023 was:

		Weighted-average
		fair value per		Weighted-average
	Number	share at grant		remaining contractual
	of shares	date		term (in years)
Outstanding at March 31, 2023	4,009,759	$	32.57	2.20
Granted	1,400,578	$	25.30
Vested	(335,134)	$	32.99
Forfeited or canceled	(314,148)	$	34.53
Outstanding at September 30, 2023	4,761,055	$	30.27	1.83

Schedule of Non-vested Performance-based Restricted Stock Units Activity

PSU activity for the six months ended September 30, 2023 was:

		Weighted-average
		fair value per		Weighted-average
	Number	share at grant		remaining contractual
	of shares	date		term (in years)
Outstanding at March 31, 2023	709,589	$	34.97	1.01
Granted	539,740	$	25.37
Vested	(55,051)	$	47.11
Forfeited or canceled	(214,760)	$	40.19
Outstanding at September 30, 2023	979,518	$	27.85	1.95